HCV genotype 3: an independent predictor of fibrosis progression in chronic hepatitis C

Related Experiment Video

Updated: Jun 20, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Stella De Nicola, Alessio Aghemo, Maria Grazia Rumi

    Journal of Hepatology
    |September 25, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
    10:23

    Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

    Published on: April 17, 2017

    Related Experiment Videos

    Last Updated: Jun 20, 2026

    A Protocol for Analyzing Hepatitis C Virus Replication
    13:04

    A Protocol for Analyzing Hepatitis C Virus Replication

    Published on: June 26, 2014

    Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
    10:23

    Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

    Published on: April 17, 2017

    Related Concept Videos

    Hepatitis01:25

    Hepatitis

    Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
    Cirrhosis II: Pathophysiology01:24

    Cirrhosis II: Pathophysiology

    Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

    Articles linked to this work by shared authors, journal, and citation graph.

    Histologic Features and Clinical Outcomes of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease.

    JAMA·2026

    Applicability of Non-Invasive Eligibility Criteria for MASH Pharmacotherapy: A Multicentre Cohort Study.

    Liver international : official journal of the International Association for the Study of the Liver·2026

    Direct-Acting Antivirals in Patients with Comorbidities for the Simplified Management of HCV Infection: An Expert Review with a Focus on Sofosbuvir-Velpatasvir.

    Viruses·2026

    Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma: Summary of the First Annual Paris International Liver Meeting 2026.

    Liver international : official journal of the International Association for the Study of the Liver·2026

    Biventricular Systolic Function and Myocardial Deformation in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Speckle-Tracking Echocardiography and Cardiac Magnetic Resonance Feature Tracking Studies.

    Journal of clinical medicine·2026

    Fatty Pancreas and Risk of Type 2 Diabetes, Chronic Kidney Disease and Cardiovascular Events: Evidence From a Population-Based Cohort.

    United European gastroenterology journal·2026

    Crosstalk along the gut-liver axis in liver disease: Clinical and mechanistic aspects.

    Journal of hepatology·2026

    Intestinal Candida albicans promotes HCC progression and anti-PD-1 resistance via IL-17A and Trem2+ macrophages.

    Journal of hepatology·2026

    Abnormal left ventricular mass as a prognostic marker for outcomes in infants and children with cirrhosis.

    Journal of hepatology·2026

    First-line durvalumab and tremelimumab in poor-prognosis unresectable hepatocellular carcinoma: Phase IIIb single-arm SIERRA study.

    Journal of hepatology·2026

    Effects of MASH risk genotypes on resmetirom efficacy in patients with MASH and fibrosis.

    Journal of hepatology·2026

    Temporal assessment of spatial and single-cell transcriptomes identifies CD226-NECTIN2 T cell-cholangiocyte interaction in bile duct inflammation.

    Journal of hepatology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us